Dr
Louise
Slope

Trainee Patent Attorney

Birmingham Office

Chemistry

Telephone. +44(0) 121 265 7930
Email. [email protected]

Experience

Louise joined HGF in September 2018 and completed a part-time distance learning course at the University of Bournemouth in 2019, obtaining a postgraduate certificate in Intellectual Property Law.

Louise's background and qualifications are in chemistry. She graduated in 2013 with a First Class MSci honours degree in Chemistry and obtained her PhD in 2018, both from the University of Birmingham. Louise's PhD research involved the de novo design of peptide architectures for use as imaging agents.

Alongside her undergraduate studies, Louise also worked in industry, undertaking two summer placements in the Research and Development team at Scott Bader.

During her PhD she spent two months working with collaborators in San Sebastian. This work was presented at several international conferences and resulted in a number of publications.

Following the completion of her PhD, Louise completed two research fellow posts at the University of Birmingham, the first in the School of Chemistry and the second in the Institute of Microbiology and Infection. Here she explored topical treatments for age-related macular degeneration, presenting her work at the ARVO Annual Meeting in Hawaii. Alongside this project, she assisted in researching the development of smart coatings for implant materials.

Qualifications

Trainee


MSCI

MSci, Chemistry, 2013

PHD

PhD, Chemistry, 2017

POSTGRADUATE DIPLOMA OR CERTIFICATE

PG Cert, Intellectual Property Law, 2019

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.